Market Research Logo

Norway Pharmaceuticals and Healthcare Report Q4 2017

Norway Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

On a cyclical basis, economic growth will provide tailwinds for Norway's pharmaceutical and healthcare market over a multi-quarter horizon. On a long-term basis, despite the relatively small drug market by regional standards, high per-capita spending on medicine and demographic trends will underpin sustained revenue-earning opportunities for innovative drugmakers. Meanwhile, the government will continue to promote the development of biomedicine research and the wider health industry, posing upside risks to drug manufacturing development over the long term.

Headline Expenditure Projections

Pharmaceuticals: NOK23.70bn (USD2.76bn) in 2016 to NOK24.03bn (USD2.77bn) in 2017; +1.4% in local currency terms and +0.3% in US dollar terms. Forecast broadly in line with the last quarter. Healthcare: NOK328.34bn (USD38.31bn) in 2016 to NOK340.50bn (USD39.29bn) in 2017; +3.7% in local currency terms and +2.5% in US dollar terms. Forecast in line with the last quarter.

Latest Updates

In August 2017, hundreds of Norwegians protested against the long approval process for new life-saving cancer medicines. It can take up to two and a half years between a drug's EU approval and its eventual use in Norwegian public hospitals.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Norway 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Norway 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Norway 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Norway 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Norway 2013-2021)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Norway 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Norway 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Norway 2015-2021)
Industry Risk/Reward Index
Western Europe Pharmaceuticals: Large Market Sizes Boost Attractiveness
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Norway 2011-2016)
Table: Healthcare Personnel (Norway 2011-2016)
Table: Healthcare Activity (Norway 2011-2016)
Research And Development
Clinical Trials
Epidemiology
Competitive Landscape
Table: The Top 15 Pharmaceutical Companies In Norway
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Demographic Forecast
Norway Demographic Forecast
Table: Population Headline Indicators (Norway 1990-2025)
Table: Key Population Ratios (Norway 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Norway 1990-2025)
Table: Population By Age Group (Norway 1990-2025)
Table: Population By Age Group % (Norway 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report